QUEBEC CITY, Jan. 24 /CNW Telbec/ - The Fonds de la recherche en santé du Québec (FRSQ), in partnership with the Ministère de la Santé et des Services sociaux (MSSS) and the pharmaceutical company Pfizer Canada, announces the
first series of projects chosen in connection with the Pfizer-FRSQ-MSSS
Chronic Disease Fund.
Created thanks to an investment of $5 million from Pfizer Canada, this
FRSQ-coordinated research grant program is aimed at evaluating chronic
disease prevention and management initiatives, supporting them
financially, fostering, where appropriate, their implementation
throughout Quebec, and making our healthcare system more efficient.
Of the different projects submitted, five were recommended for funding,
namely, those of the CSSS Champlain, the CSSS de Chicoutimi, the CSSS
de Laval, the CSSS du Rocher-Percé and the CSSS du Sud-Ouest-Verdun.
This announcement concerns investments totalling nearly $3.5 million
over the next two years.
All projects submitted to the Pfizer-FRSQ-MSSS Chronic Disease Fund
should be in line with the Ministère de la Santé et des Services sociaux' chronic disease goals, be primary care initiatives for promoting the
integration of chronic disease prevention and management, and focus on
changing clinical practices. In accordance with the FRSQ's current
rules and procedures, the applications were examined by a scientific
review committee consisting of experts from scientific and clinical
"Chronic diseases pose a significant challenge to all of Quebec society,
a challenge that is growing with the aging of the province's
population. With this new program, we hope to encourage primary care
initiatives that will foster chronic disease prevention and management
in order to evaluate them using a scientific approach and to pass the
benefits on to other settings throughout Quebec," says Yves Joanette,
President and Chief Executive Officer of the Fonds de la recherche en santé du Québec.
"This is a very innovative type of research program, for it includes
both an innovative clinical component and an evaluative research
component. Collaboration between health professionals and researchers
is a unique opportunity to recognize and disseminate original chronic
disease prevention and management initiatives throughout Quebec, adds
Dr. Howard Bergman, Vice-President of Scientific Affairs at the Fonds de la recherche en santé du Québec.
"At Pfizer, we believe that it takes more than medication to improve
chronic disease management. Strongly committed to improving people's
health, we are proud to partner with the FRSQ and the MSSS to stimulate
health innovation. This initiative attests to Pfizer Canada's desire to
maintain its involvement in the development of research and once again
reaffirms its commitment to the government's chronic disease
priorities," says Paul Lévesque, President of Pfizer Canada.
About the Fonds de la recherche en santé du Québec (FRSQ)
The mission of the Fonds de la recherche en santé du Québec (FRSQ), which reports to the Minister of Economic Development, Innovation and
Export Trade, is to support health research in order to foster the
wellness of Quebecers. Its mandate is to promote and financially
support this research, to share knowledge and train researchers, as
well as to establish partnerships necessary for the development of
Quebec's research and innovation system and advance the research
internationally. For additional information: www.frsq.gouv.qc.ca
About Pfizer Canada Inc.
Pfizer Canada Inc. is the Canadian division of Pfizer Inc., the world's
leading biopharmaceutical company. The company is one of the largest
contributors to health research in Canada. Pfizer's diversified
healthcare portfolio includes human and animal biologics,
small-molecule medicines and vaccines, nutritional products and many of
the world's best-known consumer products.
Every day, Pfizer Canada employees work to advance wellness, prevention,
treatments and cures that challenge the most feared diseases of our
time. We apply science and our global resources to improve the health
and well-being of Canadians at every stage of life. Our commitment is
reflected in everything Pfizer does, from our disease awareness
initiatives to our community partnerships, to our belief that it takes
more than medication to be truly healthy. To learn more about Pfizer's
More Than Medication philosophy and programs, visit morethanmedication.ca. To learn more about Pfizer Canada, visit pfizer.ca.
List of Funded Projects
CSSS Champlain - $699,040
The intersectorial and interprofessional type 2 diabetes follow-up
proposed in this project improves the continuum of services that has
been in place for over two years in the Réseau local de services Champlain thanks to the collaborative efforts between the network's family
physicians and the primary health care teams at the CSSS Champlain and
Charles LeMoyne Hospital. This improvement involves an increase in the
number of family physicians who provide this follow-up, the inclusion
of community pharmacists in the care team, and a more systematic
evaluation of diabetes-related risks for individuals aged 45 and up.
CSSS de Chicoutimi - $699,800
This project is aimed at implementing an intervention that will
constitute an improvement, an adaptation and a permanent part of the
services provided by the Trajectoire des services de réadaptation intégrés pour maladies
chroniques du Saguenay-Lac-St-Jean (a regional initiative offering a range of activities pertaining to
issues such as diet, physical activity and smoking cessation) in
primary care settings in the Chicoutimi and Jonquière regions, whose
CSSSs are partners in this proposal. The project relies on the success
of the Trajectoire's previous operations, on regional mobilization, and
on the experience acquired within the teams.
CSSS de Laval - $636,282
Laval's healthcare community created the TRANSIT program, which is aimed
at TRANSforming InTerprofessional practices with a view to improving
the quality of cardiovascular preventive care at the primary care
level. The overall objective of the project is to institute the TRANSIT
program at a family medicine group in order to improve care and service
coordination through a pivot nurse in a context of interprofessional
collaboration, to facilitate access to the services of nutritionists
and kinesiologists, to improve self-management support for patients and
their families, and to improve the management of clinical information.
CSSS du Rocher-Percé - $699,928
This project, with the theme of managing one's health in the
Rocher-Percé region, is characterized by two major innovations. The
delivery of interventions prescribed as part of individualized
interdisciplinary service plans is based on a group physical activity
program which takes place regularly in four localities in the region
and at points of delivery as unconventional as private gyms. In
addition, the consolidation of the technological tools currently in use
will continue to facilitate home follow-up, and a new software program
will facilitate the decentralization of practice settings and
interdisciplinary follow-up by permitting the real-time sharing of
CSSS du Sud-Ouest-Verdun (in charge) and five partnering CSSSs1 - $700,000
Continue implementing an integrated, interdisciplinary cardiometabolic
risk prevention and management program for the purpose of assisting
primary care general practitioners in managing people with diabetes
and/or hypertension, and take action on health determinants, for
example, the way lifestyle habits affect diabetes and hypertension, in
order to delay disease progression.
The Pfizer-FRSQ-MSSS Chronic Disease Fund
The purpose of the Fund, valued at $5 million, is to finance chronic
disease prevention and management projects and evaluate such projects.
In collaboration with one or more family physicians and the health and
social services research community, CSSSs are invited to submit
projects that will promote the interdisciplinary follow-up of people
with chronic diseases or the implementation of self-management tools
The applications were examined by a scientific review committee
consisting of experts from scientific and clinical settings. All the
projects chosen include a clinical component and an evaluative research
component. Priority is given to projects that are already operational,
ready to be implemented or in the process of being implemented.
Chronic Diseases in Quebec2
Slightly more than half of Quebecers aged 12 and over have at least one
16.3% of Quebecers aged 12 and over have hypertension, and 6% have
Cardiovascular disease is the leading cause of hospitalization in
Asthma affects close to 9% of Quebecers aged 12 and over, and 3.4% have
COPD (chronic obstructive pulmonary disease).
More than 10% of Quebecers aged 12 and over have arthritis.
1 The CSSS Bordeaux-Cartierville-Saint-Laurent, the CSSS de St-Léonard et
Saint-Michel, the CSSS du Coeur-de-l'Île, the CSSS Jeanne-Mance and the
CSSS de la Pointe-de-l'Île.
2 Source: Rapport d'appréciation de la performance du système de santé et de
services sociaux 2010 - État de situation portant sur les maladies
chroniques et la réponse du système de santé et de services sociaux. Commissaire à la santé et au bien-être. March 2010. 136 p.
SOURCE PFIZER CANADA INC.
For further information:
|For media requests: |
NATIONAL Public Relations
418-648-1233, ext. 235
For further information, please contact: